Chronic Anemia Workup

  • Author: Christopher D Braden, DO; Chief Editor: Barry E Brenner, MD, PhD, FACEP   more...
 
Updated: Jun 6, 2011
 

Approach Considerations

The 3 laboratory measurements that are critical in the workup of anemia are as follows:

  • Measurement of RBC indices
  • Examination of peripheral blood smear
  • Bone marrow examination (not necessary in all patients)

Additional laboratory tests that allow differentiation of anemias based on RBC index information include the following:

  • Serum iron concentration
  • Total iron-binding capacity (TIBC)
  • Serum vitamin B-12
  • Serum folate
  • Serum bilirubin
  • Liver function tests (LFTs)
  • Thyroid panel
  • Hgb electrolytes
  • Heavy metal studies

The ultimate diagnosis of chronic anemia is based on results of blood studies. In the initial emergency department (ED) evaluation, a prudent choice of labs includes the following:

  • Complete blood count (CBC) with leukocyte differential and peripheral smear
  • RBC indices
  • Reticulocyte count
  • Bilirubin

Based on the RBC indices, further blood work may be initiated in the ED. Iron studies may be performed. These can include ferritin, TIBC, total iron, and percent saturation. Typically, iron studies are helpful in the diagnosis of microcytic and normocytic anemias.

Serum vitamin B-12, folate levels, and the red cell folate level are useful in evaluating macrocytic anemias. Order concurrent liver and thyroid function studies for patients with macrocytic anemia.

Hgb electrophoresis may delineate sickle cell anemia and thalassemias.

Heavy metal studies (eg, serum lead level) may be considered when a high level of suspicion is present, historically and clinically, for heavy metal poisoning.

Imaging studies

No specific imaging tests exist for chronic anemia; however, several imaging modalities can be used in examining the underlying etiology (eg, computed tomography [CT] scanning for abdominal mass, chest radiography for histoplasmosis/coccidioidomycosis).

Bone marrow examination

Bone marrow examination may be diagnostic in cases in which workup is otherwise nonspecific. This is not a procedure performed in the acute setting.

Next

Common Lab Studies

Hematocrit

Hematocrit also is known as the packed cell volume (PCV) and indicates the percentage of RBCs in a volume of whole blood. Increased values occur with severe dehydration, erythrocytosis, polycythemia, severe burns, and shock, and in people living in high altitudes, males, and infants. Decreased values occur with anemia and the many differential diagnoses that encompass anemia (eg, hyperthyroidism, leukemia, liver disease, hemolytic reactions). Other causes of decreased hematocrit values include female sex, advanced age, and pregnancy. Hematocrit value is not reliable immediately after blood loss or blood transfusions.

Hgb concentration

Hgb concentration is expressed in grams per 100 mL of blood. Increased values can indicate severe dehydration, erythrocytosis, polycythemia, severe burns, shock, chronic obstructive pulmonary disease (COPD), or congestive heart failure (CHF). Increased values also occur in people living in high altitudes, people consuming drugs such as gentamicin or methyldopa, and infants. Decreased values indicate anemia and the many differential diagnoses that encompass anemia (eg, hyperthyroidism, leukemia, liver disease, hemolytic reactions).

Other possible causes of decreased Hgb values include overhydration, pregnancy, and drugs (eg, acetaminophen, antineoplastic agents, chloramphenicol, hydralazine, monamine oxidase inhibitors [MAOIs], nitrites, penicillin, tetracycline, sulfonamide). Each gram of Hgb has a carrying capacity of 1.34 mL of oxygen.

Mean corpuscular volume

Mean corpuscular volume (MCV) is the hematocrit divided by the RBC count. It is a measurement of the volume occupied by a single RBC and is an indicator of individual cell size. Increased values indicate differentials that encompass macrocytic anemia (eg, vitamin B-12 or folate deficiency, liver disease, alcoholism), while decreased values indicate microcytic anemia (ie, iron deficiency, thalassemia, anemia of chronic blood loss). This is the most important of the RBC indices. A normal value can appear when a wide variety of cell sizes is present (ie, macrocyte, microcyte).

Mean corpuscular Hgb concentration

Mean corpuscular Hgb concentration (MCHC) is the Hgb divided by the hematocrit. It represents the average concentration of Hgb in the red blood cells. The value is expressed as a percentage. Increased values point to spherocytosis (eg, congenital hemolytic anemia), and decreased values indicate iron deficiency, thalassemia, or macrocytic anemia.

Mean corpuscular Hgb

Mean corpuscular Hgb (MCH) is the Hgb divided by the RBC count. It represents the average weight of Hgb in the RBCs and serves to confirm the accuracy of MCV value. Increased values occur in macrocytic anemia, newborns, and infants. Decreased values indicate microcytic anemia.

Reticulocyte count and index

The first question a clinician must address is whether the anemia is due to a decreased production of RBCs or to increased destruction or loss of RBCs. The reticulocyte count is the most valuable test in answering this question.

A reticulocyte is a nonnucleated, immature RBC formed in the bone marrow. Increased values indicate accelerated erythropoiesis and can be present following treatment of anemia, after splenectomy, 3-4 days following hemorrhage, in sickle cell disease hemolytic anemia, during pregnancy, or in infants. Decreased values indicate decreased RBC production by the bone marrow and can be a result of aplastic anemia, chronic infection, or radiation therapy. A persistent reticulocyte deficiency is a poor prognostic sign.

The reticulocyte index (RI) is defined as the percent reticulocyte count divided by 2 and then multiplied by the ratio of the patient's hematocrit (or Hgb) to normal hematocrit (or Hgb). Good marrow response is defined as an RI value of 2-6.

Previous
 
 
Contributor Information and Disclosures
Author

Christopher D Braden, DO  Hematologist/Oncologist, Chancellor Center for Oncology at Deaconess Hospital; Hematologist/Oncologist, St Francis Hospital System Cancer Center

Disclosure: Nothing to disclose.

Coauthor(s)

Eric Wilke, MD  Medical Director, Traditions Emergency Medicine, College Station Medical Center

Eric Wilke, MD is a member of the following medical societies: American College of Emergency Physicians and Texas Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Roy Alson, MD, PhD, FACEP, FAAEM  Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine; Medical Director, Forsyth County EMS; Deputy Medical Advisor, North Carolina Office of EMS; Associate Medical Director, North Carolina Baptist AirCare

Roy Alson, MD, PhD, FACEP, FAAEM is a member of the following medical societies: Air Medical Physician Association, American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, North Carolina Medical Society, North Carolina Medical Society, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Jeffrey L Arnold, MD, FACEP  Chairman, Department of Emergency Medicine, Santa Clara Valley Medical Center

Jeffrey L Arnold, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Barry E Brenner, MD, PhD, FACEP  Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, Case Medical Center, University Hospitals, Case Western Reserve University School of Medicine

Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Fredrick Melik Abrahamian, DO, FACEP,to the development and writing of the source article.

References
  1. [Guideline] American College of Obstetricians and Gynecologists (ACOG). Anemia in pregnancy. Jul 2008;[Full Text].

  2. Zittermann A, Jungvogel A, Prokop S, Kuhn J, Dreier J, Fuchs U, et al. Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol. Apr 7 2011;[Medline].

  3. Omar N, Salama K, Adolf S, El-Saeed GS, Abdel Ghaffar N, Ezzat N. Major risk of blood transfusion in hemolytic anemia patients. Blood Coagul Fibrinolysis. Apr 19 2011;[Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.